SCHEMBL22858414

SCHEMBL22858414

Cn1nc(N)cc1CC1CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 1/20 0.32
▸ SMYD2 Q9NRG4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30587463 0.89 HTR6 (0.34) —
SCHEMBL28957774 0.82 PIK3CA (0.35) —
SCHEMBL24014902 0.79 KCNH2 (0.37) MPO
SCHEMBL30365630 0.78 PDE2A (0.30) —
SCHEMBL24006584 0.78 — —
SCHEMBL25623931 0.75 — —
SCHEMBL24014768 0.75 BCHE (0.32) SMYD2
SCHEMBL29284948 0.75 FPR2 (0.33) —
SCHEMBL23252618 0.74 — —
Hydrochloric Acid SCHEMBL22436806 0.74 GAA (0.41) MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127058-B Heterocyclic compound, pharmaceutical composition and application thereof 深圳国顺康医药科技有限公司 2024-06-25 — — CN disclosed
CN-114127058-A Heterocyclic compound, pharmaceutical composition and application thereof 北京国鸿生物医药科技有限公司 2022-03-01 — — CN disclosed
WO-2021000957-A1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 北京国鸿生物医药科技有限公司 2021-01-07 — — WO disclosed
WO-2021000957-A1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 北京国鸿生物医药科技有限公司 2021-01-07 — — WO disclosed
Send feedback